MDGC yields 2000000.00% · PFE yields 6.13%● Live data
📍 MDGC pulled ahead of the other in Year 1
Combined, MDGC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDGC + PFE for your $10,000?
MediaG3, Inc. engages in the design, development, and deployment of wireless broadband Internet, wireless networks, fixed and mobile Internet, communications, and media and entertainment products and services for individuals and companies of various sizes. It provides Wi-Fi and wireless networks and ultra high speed wireless broadband Internet products and solutions. The company offers point-to-point and point-to-multipoint digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. Its products include broadband wireless access base stations and customer premises equipment for fixed and mobile point-to-point digital microwave radio systems for Internet access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. The company also provides Internet and Internet-related products and services, as well as engages in residential ISP services, broadband wholesale marketing, and retail direct fiber connections to the Internet for large and small businesses. Further, its online store offers Internet related products and services. MediaG3, Inc. was incorporated in 2005 and is headquartered in San Jose, California.
Full MDGC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.